Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Assessing the Management of Gastrointestinal and Urogenital Bleeding Events in Patients With Atrial Fibrillation Treated With Dabigatran Etexilate

NCT02022020 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02022020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02022020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Assessing the Management of Gastrointestinal and Urogenital Bleeding Events in Patients With Atrial Fibrillation Treated With Dabigatran Etexilate
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
October 31, 2015
Enrollment
220 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation